MedPath
FDA Approval

Adapalene and Benzoyl Peroxide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 27, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Adapalene(3 mg in 1 g)
Benzoyl peroxide(25 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Taro Pharmaceuticals Inc.

Taro Pharmaceuticals U.S.A., Inc.

206263295

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Adapalene and Benzoyl Peroxide

Product Details

NDC Product Code
51672-1384
Application Number
ANDA209148
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
December 27, 2022
docusate sodiumInactive
Code: F05Q2T2JA0Class: IACT
AdapaleneActive
Code: 1L4806J2QFClass: ACTIBQuantity: 3 mg in 1 g
Code: W9WZN9A0GMClass: ACTIBQuantity: 25 mg in 1 g
poloxamer 124Inactive
Code: 1S66E28KXAClass: IACT
edetate disodiumInactive
Code: 7FLD91C86KClass: IACT
glycerinInactive
Code: PDC6A3C0OXClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S)Inactive
Code: 5F4963KLHSClass: IACT
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath
Adapalene and Benzoyl Peroxide - FDA Approval | MedPath